T Cell Cross-Reactivity May Explain the Large Variation in How Patients Respond to Checkpoint Inhibitors
Scandinavian Journal of Immunology - United Kingdom
doi 10.1111/sji.12643
Full Text
Open PDFAbstract
Available in full text
Date
February 27, 2018
Authors
Publisher
Wiley